IL213768A0 - 5-ht2a and 5-ht2b receptor antagonists for treating stenosis of the spinal canal - Google Patents
5-ht2a and 5-ht2b receptor antagonists for treating stenosis of the spinal canalInfo
- Publication number
- IL213768A0 IL213768A0 IL213768A IL21376811A IL213768A0 IL 213768 A0 IL213768 A0 IL 213768A0 IL 213768 A IL213768 A IL 213768A IL 21376811 A IL21376811 A IL 21376811A IL 213768 A0 IL213768 A0 IL 213768A0
- Authority
- IL
- Israel
- Prior art keywords
- ht2a
- receptor antagonists
- spinal canal
- ht2b receptor
- treating stenosis
- Prior art date
Links
- 102000049773 5-HT2A Serotonin Receptor Human genes 0.000 title 1
- 108010072564 5-HT2A Serotonin Receptor Proteins 0.000 title 1
- 102000006969 5-HT2B Serotonin Receptor Human genes 0.000 title 1
- 108010072584 5-HT2B Serotonin Receptor Proteins 0.000 title 1
- 208000031481 Pathologic Constriction Diseases 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 208000037804 stenosis Diseases 0.000 title 1
- 230000036262 stenosis Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08172859 | 2008-12-23 | ||
| PCT/EP2009/067768 WO2010072774A2 (de) | 2008-12-23 | 2009-12-22 | Mittel zur behandlung der spinalkanalstenose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL213768A0 true IL213768A0 (en) | 2011-07-31 |
Family
ID=40527906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL213768A IL213768A0 (en) | 2008-12-23 | 2011-06-23 | 5-ht2a and 5-ht2b receptor antagonists for treating stenosis of the spinal canal |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP2367543A2 (zh) |
| JP (1) | JP2012513446A (zh) |
| KR (1) | KR20110098965A (zh) |
| CN (1) | CN102271667A (zh) |
| AU (1) | AU2009331469A1 (zh) |
| BR (1) | BRPI0923556A2 (zh) |
| CA (1) | CA2748163A1 (zh) |
| IL (1) | IL213768A0 (zh) |
| MX (1) | MX2011006852A (zh) |
| SG (1) | SG172315A1 (zh) |
| WO (1) | WO2010072774A2 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9657020B2 (en) | 2015-01-20 | 2017-05-23 | Xoc Pharmaceuticals, Inc. | Ergoline compounds and uses thereof |
| CA3064274A1 (en) * | 2017-06-01 | 2018-12-06 | Xoc Pharmaceuticals, Inc. | Ergoline derivatives for use in medicine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2229297C2 (ru) | 1998-09-01 | 2004-05-27 | Ниссан Кемикал Индастриз, Лтд. | Терапевтический агент для лечения стеноза позвоночного канала |
| WO2004043491A1 (ja) | 2002-11-14 | 2004-05-27 | Ono Pharmaceutical Co., Ltd. | 脊柱管狭窄症治療剤 |
| US20070167403A1 (en) | 2003-04-03 | 2007-07-19 | Yoshifumi Takenobu | Remedy for spinal canal stenosis |
| DE102006013307B3 (de) | 2006-03-21 | 2007-10-04 | Ergonex Pharma Gmbh | Tergurid/Protergurid zur Behandlung von chronischen Schmerzen |
-
2009
- 2009-12-22 WO PCT/EP2009/067768 patent/WO2010072774A2/de active Application Filing
- 2009-12-22 SG SG2011045671A patent/SG172315A1/en unknown
- 2009-12-22 MX MX2011006852A patent/MX2011006852A/es not_active Application Discontinuation
- 2009-12-22 AU AU2009331469A patent/AU2009331469A1/en not_active Abandoned
- 2009-12-22 KR KR1020117017268A patent/KR20110098965A/ko not_active Application Discontinuation
- 2009-12-22 CA CA2748163A patent/CA2748163A1/en not_active Abandoned
- 2009-12-22 BR BRPI0923556A patent/BRPI0923556A2/pt not_active Application Discontinuation
- 2009-12-22 CN CN2009801524590A patent/CN102271667A/zh active Pending
- 2009-12-22 JP JP2011542819A patent/JP2012513446A/ja active Pending
- 2009-12-22 EP EP09795786A patent/EP2367543A2/de not_active Withdrawn
-
2011
- 2011-06-23 IL IL213768A patent/IL213768A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010072774A2 (de) | 2010-07-01 |
| MX2011006852A (es) | 2011-07-20 |
| CA2748163A1 (en) | 2010-07-01 |
| CN102271667A (zh) | 2011-12-07 |
| JP2012513446A (ja) | 2012-06-14 |
| BRPI0923556A2 (pt) | 2016-01-26 |
| AU2009331469A1 (en) | 2011-07-21 |
| SG172315A1 (en) | 2011-07-28 |
| KR20110098965A (ko) | 2011-09-02 |
| WO2010072774A3 (de) | 2010-09-23 |
| EP2367543A2 (de) | 2011-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0822590D0 (en) | Orthotic prosthetic cushioned device and method of making the same | |
| ZA201004227B (en) | Bicyclic derivatives for use in the treatment of androgen receptor associated conditions | |
| EP2215049A4 (en) | P2X3 RECEPTOR ANTAGONISTS USED IN THE TREATMENT OF PAIN | |
| EP2215048A4 (en) | P2X3 RECEPTOR ANTAGONISTS USED IN THE TREATMENT OF PAIN | |
| SI2292231T1 (sl) | Terapevtsko sredstvo za stenozo spinalnega kanala | |
| EP2358371A4 (en) | ANTAGONISTS OF THE P2X3 RECEPTOR FOR THE TREATMENT OF PAIN | |
| IL196998A0 (en) | Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders | |
| HK1121448A1 (zh) | 伯胺及其衍生物為 血清素受體調節器並有效用於治療與其有關的障礙 | |
| PL2405835T3 (pl) | Urządzenie do odbudowy kostnej kręgosłupa | |
| EP2411001A4 (en) | P2X3 RECEPTOR ANTAGONISTS FOR PAIN TREATMENT | |
| EP2413844A4 (en) | MONOLITHIC ORTHOPEDIC IMPLANT WITH RANGE OF WORKED SURFACE | |
| ZA200905203B (en) | Adjustable intervertebral implant | |
| GB0611154D0 (en) | Novel receptor antagonists and their methods of use | |
| IL215690A0 (en) | Thiazole derivatives and their use as p2y12 receptor antagonists | |
| EP2445346A4 (en) | OXOHETEROCYCLIC FUSIONED PYRIMIDINE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE | |
| PT2344086E (pt) | Prótese ortopédica | |
| EP2350024A4 (en) | IMPROVED METHOD FOR THE PRODUCTION OF ENDOTHELIN RECEPTOR ANTAGONISTS | |
| GB0703249D0 (en) | Removal of spinal prostheses | |
| ZA201001264B (en) | 1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus | |
| IL198334A0 (en) | 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as p2y12 receptor antagonists | |
| HK1158640A1 (zh) | 作為 受體拮抗劑的取代的 -哌嗪基 -噠嗪 | |
| IL193669A0 (en) | Apparatus for the treatment of bruxism | |
| EP2475390A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF TYROSINE KINASE RECEPTOR MEDIATION DISEASES OR DISORDERS | |
| IL210290A0 (en) | Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis | |
| EP2146573A4 (en) | GALENIC FORMS IN UNIT DOSES AND METHODS OF TREATING AND PREVENTING THROMBOSIS USING THROMBOXANE RECEPTOR ANTAGONISTS |